N-METHYL-1-(PYRIMIDIN-2-YL)METHANAMINE 2HCL, 95.0%, 1g

Methyl 3-(4-methoxyphenyl)propiolate, 95.0%, 5g

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

N-Phenyl-[1,1'-biphenyl]-4-amine, 95.0%, 5g

ditert-butyl3,3'-(pyrimidine-4,6-diylbis(oxy))bis(methylene)dipiperidine-1-carboxylate, 250mg

4-Methoxyphenyl beta-D-Glucopyranoside>97.0%(HPLC)25g

METHYL 7H-PYRROLO[2,3-D]PYRIMIDINE-2-CARBOXYLATE, 95.0%, 500mg

N-(3-methoxypropyl)-1-methyl-4-piperidinamine disuccinate, 95.0%, 5g

1,6-Dioxaspiro[2.5]octane, 95.0%, 5g

2,5-Difluoro-4-methylbenzoic acid, 96.0%, 100g

2-(Trifluoromethyl)benzyl alcohol, 97.0%, 100g

N-(4-Aminophenyl)-N-cyclopropyl-2-(dimethylamino)acetamide, 98%, 250mg

4-Ethoxycyclohexanecarboxylic acid, 97%, 250mg